Presentation is loading. Please wait.

Presentation is loading. Please wait.

Piperacillin/tazobactam versus imipenem/cilastatin for severe diabetic foot infections: a prospective, randomized clinical trial in a university hospital 

Similar presentations


Presentation on theme: "Piperacillin/tazobactam versus imipenem/cilastatin for severe diabetic foot infections: a prospective, randomized clinical trial in a university hospital "— Presentation transcript:

1 Piperacillin/tazobactam versus imipenem/cilastatin for severe diabetic foot infections: a prospective, randomized clinical trial in a university hospital  N. Saltoglu, A. Dalkiran, T. Tetiker, H. Bayram, Y. Tasova, C. Dalay, M. Sert  Clinical Microbiology and Infection  Volume 16, Issue 8, Pages (August 2010) DOI: /j x Copyright © 2010 European Society of Clinical Infectious Diseases Terms and Conditions

2 FIG. 1 Trial flow-diagram.
Clinical Microbiology and Infection  , DOI: ( /j x) Copyright © 2010 European Society of Clinical Infectious Diseases Terms and Conditions


Download ppt "Piperacillin/tazobactam versus imipenem/cilastatin for severe diabetic foot infections: a prospective, randomized clinical trial in a university hospital "

Similar presentations


Ads by Google